ArTS Archivio della ricerca di Trieste

LUCAFÒ, MARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.180
EU - Europa 4.993
AS - Asia 3.798
SA - Sud America 572
AF - Africa 164
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.726
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.057
SG - Singapore 1.420
PL - Polonia 1.414
IT - Italia 1.138
CN - Cina 862
VN - Vietnam 489
DE - Germania 461
BR - Brasile 424
SE - Svezia 408
HK - Hong Kong 385
FI - Finlandia 265
FR - Francia 263
GB - Regno Unito 213
RU - Federazione Russa 176
KR - Corea 168
UA - Ucraina 121
NL - Olanda 117
IN - India 108
IE - Irlanda 80
TR - Turchia 77
BG - Bulgaria 70
AR - Argentina 51
CA - Canada 50
MA - Marocco 46
AT - Austria 45
BE - Belgio 44
MX - Messico 44
JP - Giappone 43
BD - Bangladesh 42
SN - Senegal 31
ZA - Sudafrica 31
ES - Italia 28
EC - Ecuador 26
SA - Arabia Saudita 26
ID - Indonesia 21
IQ - Iraq 21
PK - Pakistan 20
CH - Svizzera 17
CO - Colombia 17
PH - Filippine 17
CZ - Repubblica Ceca 14
LT - Lituania 14
PE - Perù 13
VE - Venezuela 13
CL - Cile 12
AU - Australia 11
GR - Grecia 11
RO - Romania 11
RS - Serbia 11
SI - Slovenia 11
EG - Egitto 10
DK - Danimarca 9
DZ - Algeria 9
MY - Malesia 9
TH - Thailandia 9
HR - Croazia 8
JO - Giordania 8
PT - Portogallo 8
PY - Paraguay 8
TN - Tunisia 8
UZ - Uzbekistan 8
IL - Israele 7
KW - Kuwait 7
NO - Norvegia 7
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
KE - Kenya 6
BA - Bosnia-Erzegovina 5
HU - Ungheria 5
IR - Iran 5
JM - Giamaica 5
LB - Libano 5
MD - Moldavia 5
AL - Albania 4
BO - Bolivia 4
EU - Europa 4
NP - Nepal 4
PA - Panama 4
UY - Uruguay 4
CI - Costa d'Avorio 3
CR - Costa Rica 3
ET - Etiopia 3
KZ - Kazakistan 3
LV - Lettonia 3
MU - Mauritius 3
NG - Nigeria 3
OM - Oman 3
QA - Qatar 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
EE - Estonia 2
GE - Georgia 2
GH - Ghana 2
GT - Guatemala 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LC - Santa Lucia 2
Totale 15.696
Salva come PNG Salva come JPEG
Città #
Warsaw 1.319
Singapore 832
Ashburn 736
Fairfield 563
Chandler 451
Trieste 429
Woodbridge 428
Hong Kong 365
San Jose 341
Ann Arbor 326
Houston 301
Wilmington 253
Munich 252
Seattle 246
Beijing 188
Helsinki 174
Cambridge 173
Seoul 151
Ho Chi Minh City 150
Hanoi 128
Hefei 124
Jacksonville 120
Princeton 110
Boardman 108
Los Angeles 107
Council Bluffs 98
Dallas 95
Chicago 91
Santa Clara 81
Lauterbourg 80
Moscow 77
Dublin 74
Sofia 69
Columbus 66
Zgierz 64
London 60
Rome 56
Dearborn 55
Frankfurt am Main 52
The Dalles 51
Milan 49
Izmir 43
New York 40
Casablanca 39
São Paulo 38
Brussels 36
Buffalo 32
Dakar 31
Lappeenranta 30
Shanghai 30
Vienna 29
Atlanta 27
Dong Ket 26
Düsseldorf 25
Orem 25
Guangzhou 24
San Diego 24
Falls Church 23
Redwood City 23
Manchester 20
Tokyo 20
Amsterdam 19
Johannesburg 19
Mumbai 19
Nuremberg 19
Denver 18
Chennai 17
Redondo Beach 17
Brooklyn 16
Stockholm 16
Turku 16
Bremen 15
Da Nang 15
Des Moines 15
Haiphong 15
Montreal 15
Venice 15
Nottingham 14
Portsmouth 14
Jeddah 13
Jinan 13
Phoenix 13
Udine 13
Wroclaw 13
Belo Horizonte 12
Florence 12
Nanjing 12
Toronto 12
Washington 12
Brno 11
Guayaquil 11
Kyiv 11
Mexico City 11
Rio de Janeiro 11
Bari 10
Bologna 10
Chengdu 10
Jyväskylä 10
Lima 10
Mestre 10
Totale 10.612
Salva come PNG Salva come JPEG
Nome #
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis 531
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 497
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 470
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response 470
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 461
Pharmacogenetics of thiopurines 447
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients 409
Identification and Characterization of a Novel Family of Cysteine-Rich Peptides (MgCRP-I) from Mytilus galloprovincialis 369
Pharmacogenetics of treatments for inflammatory bowel disease 353
A Cationic [60] Fullerene Derivative Reduces Invasion and Migration of HT-29 CRC Cells in Vitro at Dose Free of Significant Effects on Cell Survival 318
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 314
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia 304
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 300
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease 298
Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease 279
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 270
Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy 263
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 259
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events 257
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease 246
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 245
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients 236
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort 229
MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. 228
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 228
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease 224
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay 224
Pro-inflammatory effects of palytoxin: An: in vitro study on human keratinocytes and inflammatory cells 222
RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A 216
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor 216
Hydrophilic polymer coated monodispersed Fe3O4 nanostructures and their cytotoxicity 200
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs 199
Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance 197
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 190
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease 189
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 181
Emerging molecular mechanisms underlying cancer metastasis: the rising role of the long non-coding RNA GAS5 177
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention 177
MICRORNAS ARE INVOLVED IN GLUCOCORTICOID RESISTANCE REVERSION BY RAPAMYCIN THROUGH SUPPRESSION OF THE JNK SIGNALING PATHWAY 175
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 174
Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa 172
Expression profiles of the lncRNA antisense GAS5-AS1 in colon biopsies from pediatric inflammatory bowel disease patients and its role in regulating sense transcript GAS5 166
Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients 166
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease 164
Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease 161
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway 158
Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel disease 156
Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency 156
Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia 156
A Validated HPLC-Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside 152
Patient-derived organoids for therapy personalization in inflammatory bowel diseases 150
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 146
Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease 146
Sedation and analgesia in children with cerebral palsy: a narrative review 144
Insights into the cellular pharmacokinetics and pharmacodynamics of thiopurine antimetabolites in a model of human intestinal cells 144
Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease 143
PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells 142
Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook 141
Preanalytical Stability of 13 Antibiotics in Biological Samples: A Crucial Factor for Therapeutic Drug Monitoring 141
Microbiota and drug response in inflammatory bowel disease 139
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report 138
SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells 138
DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease 136
A patent review of anticancer glucocorticoid receptor modulators (2014-present) 123
Neuron-Derived Extracellular Vesicles miRNA Profiles Identify Children Who Experience Adverse Events after Ketamine Administration for Procedural Sedation 120
iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy 119
Time-efficient strategies in human iPS cell-derived pancreatic progenitor differentiation and cryopreservation: advancing towards practical applications 110
Monoclonal antibodies against pediatric ulcerative colitis: a review of clinical progress 109
Pharmacogenomics of antibiotics 106
Clinical application of thiopurine pharmacogenomics in pediatrics 105
Klebsiella pneumoniae contributes to altered cytotoxicity of thiopurines in vitro: Possible implications of biotransformation and bacterial metabolism 102
The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity 100
NLRP3 promoter methylation as a predictive biomarker for glucocorticoid response in patients with inflammatory bowel disease 99
Post-procedure sedation and apnea linked to ion channel variant: a case report on dexmedetomidine-propofol interaction 94
Azathioprine Metabolites in Erythrocytes and DNA for Therapy Monitoring in Very Early Onset Inflammatory Bowel Disease Pediatric Patients 92
Pharmacological Modulation of NLRP3: From Therapy Personalization to Innovative Drugs 52
PIEZO1 Channels Modulate the Small Extracellular Vesicle Release in C2C12 Cells 43
Unraveling the cellular mechanisms of thiopurine-induced pancreatitis in pediatric inflammatory bowel disease: Insights from induced pluripotent stem cell models 38
Unraveling Novel Genetic Determinants of Thiopurine Response Via TWAS 35
Inosine-Triphosphate-Pyrophosphatase Activity as a Potential Predictor of Methotrexate Remission in Juvenile Idiopathic Arthritis 8
Totale 16.152
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.108
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021299 0 0 0 0 0 0 0 0 0 137 62 100
2021/2022901 63 51 54 80 40 85 78 28 100 89 36 197
2022/20231.324 120 215 94 197 115 209 15 119 129 27 48 36
2023/2024989 48 51 37 47 87 96 180 206 31 34 111 61
2024/20252.879 43 153 234 240 215 324 243 235 367 341 222 262
2025/20265.085 577 292 385 495 510 430 822 211 732 631 0 0
Totale 16.152